Depressive disorders in epilepsy

Neurology

Volumn 53, Issue SUPPL. 2, 1999, Pages

  Kanner, Andres M ^a,c   Nieto, Juan Carlos Rivas ^b  

^a RUSH MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; GABAPENTIN; IMIPRAMINE; LAMOTRIGINE; LITHIUM; MAPROTILINE; MIANSERIN; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE;

ANTICONVULSANT THERAPY; DEPRESSION; DRUG INDUCED DISEASE; ELECTROCONVULSIVE THERAPY; EPILEPSY; HUMAN; MENTAL DISEASE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOTHERAPY; REVIEW; RISK FACTOR; SEIZURE;

DEPRESSIVE DISORDER; EPILEPSY; HUMANS;

EID: 0033595436     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (123)

1. Mendez MF, Cummings J, Benson D, et al. Depression in epilepsy. Significance and phenomenology. Arch Neurol 1986; 43:766-770.
2. Standage K, Fenton G. Psychiatric symptoms profiles of patients with epilepsy: a controlled investigation. Psychol Med 1975;5:152-160.
3. Robertson M, Trimble M, Townsend H, et al. The phenomenology of depression in epilepsy. Epilepsia 1987;28:364-372.
4. Kogeorgos J, Fonagy P, Scott D, et al. Psychiatric symptoms patterns of chronic epileptics attending a neurological clinic: a controlled investigation. Br J Psychiatry 1982;140:236-244.
5. Mungas D. Interictal behavior abnormality in temporal lobe epilepsy. Arch Gen Psychiatry 1982;39:108-111.
6. Bear D, Fedio P. Quantitative analysis of interictal behavior in temporal lobe epilepsy. Arch Neurol 1977;34:454-460.
7. Rodin E, Schmaltz S. The Bear Fedio Personality Inventory and temporal lobe epilepsy. Neurology 1984;34:591-596.
8. Hauser W, Kurland L. The epidemiology of epilepsy in Rochester, Minnesota, 1935-1967. Epilepsia 1975;16:1-66.
9. Lewis A. Melancholia: a historical review. J Ment Sci 1934; 80:1-42.
10. Forsgren L, Nystrom L. An incident case referent study of epileptic seizures in adults. Epilepsy Res 1990;6:66-81.
11. Hesdorffer DC, Ludvigsson P, Hauser WA, Olafsson E. Depression is a risk factor for epilepsy in children [abstract]. Epilepsia 1998;39(suppl. 6):222.
12. Betts T. Depression, anxiety, and epilepsy. In: Reynolds E, Trimble M, eds. Epilepsy and psychiatry. New York: Churchill Livingstone, 1981, 60-71.
13. Currie S, Heathfield K, Henson R. Clinical course and prognosis of temporal lobe epilepsy. A survey of 666 patients. Brain 1971;92:173-190.
14. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Rev. 3rd ed. Washington, DC; American Psychiatric Press, 1987.
15. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC; American Psychiatric Press, 1994.
16. Victoroff J, Benson F, Grafton S. Depression in complex partial seizures. Electroencephalography and cerebral metabolic correlates. Arch Neurol 1994;51:155-163.
17. Brent D. Overrepresentation of epileptics in a consecutive series of suicide attempters seen at a children's hospital. J Am Acad Child Psychiatry 1986;25:242-246.
18. Victoroff J, Benson D, Engel J. Interictal depression in patients with medically intractable complex partial seizures: electroencephalography and cerebral metabolic correlates. Ann Neurol 1990;28:221.
19. Robertson M. Carbamazepine and depression. Int J Clin Psychopharmacol 1987;2:23-35.
20. Ardila A, Montanez P, Bernal B. Partial psychic seizures and brain organization. Int J Neurosci 1986;30:23-32.
21. Williams D. The structure of emotions reflected in epileptic experiences. Brain 1956;79:29-67.
22. Weil A. Depressive reactions associated with temporal lobe uncinate seizures. J Nerv Ment Dis 1955;121:505-510.
23. Daly D. Ictal affect. Am J Psychiatry 1958;115:97-108.
24. Mulder D, Daly D. Psychiatric symptoms associated with lesions of the temporal lobe. JAMA 1952;150:173-176.
25. Reynolds J. Epilepsy: its symptoms, treatment and relation to the chronic convulsive diseases. London: Churchill, 1861.
26. Weil A. Ictal emotions occurring in temporal lobe dysfunction. Arch Neurol 1959;1:87-97.
27. Perrine K, Congett S. Neurobehavioral problems in epilepsy. Neurol Clin North Am 1994;12:129-152.
28. Soto A, Kanner A, Hershkowitz L. Postictal psychiatric symptoms in patients with poorly controlled seizures: a prevalence study [abstract]. Epilepsia 1997;38(suppl. 8):155.
29. Kanner A, Soto A. Ictal recordings in postictal psychosis and postictal depression [abstract]. Neurology 1998;50:A397.
30. Robertson M. Epilepsy and mood. In: Trimble M, ed. Epilepsy, behavior and cognitive function. New York: John Wiley & Sons, 1988:145-157.
31. Robertson M. Depression in patients with epilepsy reconsidered. In: Pedley T, ed. Recent advances in epilepsy. Vol. 4. Edinburg: Churchill Livingstone, 1988;205.
32. Mendez MF, Doss R. Ictal and psychiatric aspects of suicide among epileptics. Int J Psychiatr Med 1992;22:231-238.
33. Mendez MF, Lanska D, Manon-Espaillet R. Causative factors for suicide attempts by overdose in epileptics. Arch Neurol 1989;46:1065-1068.
34. Hancock J, Bevilacqua A. Temporal lobe dysrythmia and impulsive or suicidal behavior. South Med J 1971;64:1189-1193.
35. Anatassopoulos G, Kokkini D. Suicidal attempts in psychomotor epilepsy. Behav Neuropsychol 1969;1:11-16.
36. Robertson M. Depression in patients with epilepsy: an overview. Semin Neurol 1991;11:182-189.
37. Hermann B, Whitman S. Psychosocial predictors of interictal depression. J Epilepsy 1989;2:231-237.
38. Blumer D, Zielinski J. Pharmacologic treatment of psychiatric disorders associated with epilepsy. J Epilepsy 1988;1: 135-150.
39. Mendez MF, Doss RC, Taylor JL, Salguero P. Interictal depression in epilepsy: relationship to seizure variables. J Nerv Ment Dis 1993;181:444-447.
40. Blumer D. Epilepsy and disorders of mood. In: Smith D, Treiman D, Trimble M, eds. Neurobehavioral problems in epilepsy. New York: Raven Press, 1991:185-195.
41. Blumer D, Montouris G, Hermann B. Psychiatric morbidity in seizure patients on a neurodiagnostic monitoring unit. J Neuropsychol Clin Neurosci 1995;7:445-456.
42. Hermann BP, Seidenberg M, Haltiner A, Wyler AR. Mood states in unilateral temporal lobe epilepsy. Biol Psychiatry 1991;30:1205-1218.
43. Indaco A, Carrieri P, Nappi C. Interictal depression in epilepsy. Epilepsy Res 1992;12:45-50.
44. Kraepelin E. Psychiatrie. Vol 3. 8th ed. Leipzig: Johann Ambrosius Barth, 1923.
45. Robertson M. Depression in patients with epilepsy: An overview and clinical study. In: Trimble M, ed. The psychopharmacology of epilepsy. New York: John Wiley & Sons, 1985:65.
46. Robertson M. Ictal and Interictal Depression in patients with epilepsy. In: Trimble M, ed. Aspects of epilepsy and psychiatry. New York: John Wiley & Sons, 1986:213-233.
47. Robertson M. The organic contribution to depressive illness in patients with epilepsy. J Epilepsy 1989;2:189-230.
48. Robertson M. Depression in epilepsy. In: Trimble M, ed. Women and epilepsy. New York: John Wiley & Sons, 1991: 223-242.
49. Barraclough B. The suicide rate of epilepsy. Acta Psychiatry Scand 1987;76:339-345.
50. Matthews W, Barabas G. Suicide and epilepsy: a review of the literature. Psychosomatics 1981;22:515-524.
51. Wannamaker B. Unexplained mortality in epilepsy: a perspective of death of persons with epilepsy [abstract]. Proc 15th Epilepsy Int Symp 1983;
52. Batzel L, Dodrill C. Emotional and intellectual correlates of unsuccessful suicide attempts in people with epilepsy. J Clin Psychol 1986;42:699-702.
53. Diehl L. Epilepsie und Suizid. Psychol Neurol Med Psychol 1986;38:625-633.
54. Tucker G, Price T, Johson V. Phenomenology of temporal lobe dysfunction: a link to atypical psychosis - a series of cases. J Nerv Ment Dis 1986;174:348-356.
55. Taylor D, Marsh S. Implications of long term follow up studies in epilepsy: with a note on the cause of death [abstract]. In: Penry J, ed. Epilepsy: the 8th International Symposium. New York: Raven Press, p 27.
56. Lindsay J, Ounstead C, Richards P. Long term outcome in children with temporal lobe seizures: Social outcome and childhood factors. Dev Med Child Neurol 1979;21:285-298.
57. Prudhomme C. Epilepsy and suicide. J Nerv Ment Dis 1941; 94:722-731.
58. Khron W. Causes of death among epileptics. Epilepsia 1963; 4:315-321.
59. Sillanpaa M. Medico social prognosis of children with epilepsy. Epidemiological study and analysis of 245 patients. Acta Paediatr Scand 1973(suppl. 237);93-104.
60. Zielinski J. Epilepsy and mortality rate and cause of death. Epilepsia 1974;15:191-201.
61. Dongier S. Statistical study of clinical and electroencephalographic manifestation of 536 psychotic episodes occurring in 516 epileptics between clinical seizures. Epilepsia 1959/60;1: 117-142.
62. Septien L, Giroud M, Didi-Roy R. Depression and partial epilepsy: relevance of laterality of the epileptic focus. Neurol Res 1993;15:136-138.
63. Roy A. Some determinants of affective symptoms in epileptics. Can J Psychol 1979;24:554-556.
64. Stevens J. Interictal clinical manifestation of complex partial seizures. In: Penry J, Daly D, eds. Complex partial seizures and their treatment. Vol. 11. New York: Raven Press, Adv Neurol 1975:85.
65. Altshuler L. Depression and epilepsy. In: Devinsky O, Theodore W, eds. Epilepsy and behavior. New York: Wiley-Liss, 1991. 47-65.
66. Dodrill C, Batzel L. Interictal behavioral features of patients with epilepsy. Epilepsia 1986;27:S64-72.
67. Mendez M, Engebrit D, Doss R. The relationship of epileptic auras and psychological attributes. J Neuropsychol Clin Neurosci 1996;8:287-292.
68. Bromfield E, Altshuler L, Leiderman D. Cerebral metabolism and depression in patients with complex partial seizures [abstract]. Epilepsia 1990;31:625.
69. Collaborative Group for Epidemiology of Epilepsy. Reactions to antiepileptic drugs: a multicenter survey of clinical practice. Epilepsia 1986;27:323-330.
70. McConnell H, Duncan D. Treatment of psychiatric comorbidity in epilepsy. In: McConnell H, Snyder P, eds. Psychiatric comorbidity in epilepsy. Washington, DC: American Psychiatric Press, 1998:245-361.
71. Wyler A, Richey E, Hermann B. Comparison of scalp to subdural recordings for localizing epileptogenic foci. J Epilepsy 1989;2:91-96.
72. Brent D, Crumrine P, Varma R. Phenobarbital treatment and major depressive disorder in children with epilepsy. Pediatrics 1987;80:909-917.
73. Ferrari N, Barabas G, Matthews W. Psychological and behavioral disturbance among epileptic children treated with barbiturate anticonvulsants. Am J Psychiatry 1983;140:112-113.
74. Smith D, Collins J. Behavioral effects of carbamazepine, phenobarbital, phenytoin and primidone. Epilepsia 1987;28:598.
75. Barabas G, Matthews W. Barbiturate anticonvulsants as a cause of severe depression. Pediatrics 1988;82:284-285.
76. Mackay A. Self-poisoning: a complication of epilepsy. Br J Psychiatry 1979;134:277-282.
77. Hawton K, Fagg J, Marsack P. Association between epilepsy and attempted suicide. J Neurol Neurosurg Psychiatry 1980; 43:168-170.
78. Ring H, Reynolds E. Vigabatrin and behavior disturbance. Lancet 1990;335:970.
79. Ring H, Heller A, Farr I. Vigabatrin: rational treatment for chronic epilepsy. J Neurol Neurosurg Psychiatry 1990;53: 1051-1055.
80. Ring H, Reynolds E. Vigabatrin. In: Pedley T, ed. Recent advances in epilepsy, Vol. 5. Edinburgh: Churchill Livingstone, 1992:177.
81. McConnell H, Duffy J, Cress K. Behavioral effects of felbamate. J Neuropsychiatr Clin Neurosci 1996;8:341-346.
82. Chaplin J, Yepez R, Shorvon S. A quantitative approach to measuring the social effects of epilepsy. Neuroepidemiology 1990;9:151-158.
83. Dell J. Social dimension of epilepsy: stigma and response. In: Whitman S, Hermann B, eds. Psychopathology in epilepsy: social dimensions. New York: Oxford University Press, 1986: 185-210.
84. Jacoby A. Felt versus enacted stigma: a concept revisited. Soc Sci Med 1994;38:269-274.
85. Scambler G. Sociological aspects of epilepsy. In: Hopkins A, ed. Epilepsy. New York: Demos, 1987:497-510.
86. DeVellis R, DeVellis B, Wallston B. Epilepsy and learned helplessness. Basic Appl Soc Psychol 1980;1:241-253.
87. Hermann B, Whitman S. Psychosocial predictors of interictal depression. J Epilepsy 1989;2:231-237.
88. Dodrill C. Neuropsychology. In: Laidlaw J, Richens A, Chadwick D, eds. A textbook of epilepsy. 4th ed. London: Churchill Livingstone, 1993:
89. Craig C, Oxley J. Social aspects of epilepsy. In: Laidlaw J, Richens A, Oxley J, eds. A textbook of epilepsy. 3rd ed. London: Churchill Livingstone, 1988:
90. Goldstein J, Seidenberg M, Peterson R. Fear of seizures and behavioral functioning in adults with epilepsy. J Epilepsy 1990;3:101-106.
91. Mittan R. Fear of seizures. In: Whitman S, Hermann B, eds. Psychopathology in epilepsy: social dimensions. New York: Oxford University Press, 1986:90-121.
92. Roth D Goode K, Williams V. Physical exercise, stressful life experience, and depression in adults with epilepsy. Epilepsia 1994;35:1248-1255.
93. Brown S, Reynolds E. Cognitive impairment in epileptic patients. In: Reynolds E, Trimble M, eds. Epilepsy and psychiatry Edinburgh: Churchill Livingstone, 1981:147.
94. Sorensen A, Hansen H, Hogenhaven H. Ego functions in epilepsy Acta Psychiatr Scand 1988;78:211-221.
95. Matthews C. The neuropsychology of epilepsy: an overview. J Clin Exp Neuropsychol 1992;14:133-143.
96. Robertson M, Trimble M. The treatment of depression in patients with epilepsy. A double blind trial. J Affect Disord 1985;9:127-136.
97. Dailey J, Naritoku D. Antidepressants and seizures: clinical anecdotes overshadow neuroscience. Biochem Pharmacol 1996;52:1323-1329.
98. Jobe P, Laird H. Neurotransmitter abnormalities as determinants of seizure susceptibility and intensity in the genetic models of epilepsy. Biochem Pharmacol 1981;30:3137-3144.
99. Kalichman M. Neurochemical correlates of the kindling model of epilepsy. Neurosci Biobehav Rev 1982;6:165-181.
100. Snead O. On the sacred disease: the neurochemistry of epilepsy Int Rev Neurobiol 1983;24:93-180.
101. Rosenstein D, Nelson J, Jacobs S. Seizures associated with antidepressants: a review. J Clin Psychiatry 1993;54:289-299.
102. Preskorn S, Fast G. Tricyclic antidepressant induced seizures and plasma drug concentration. J Clin Psychiatry 1992;53:160-162.
103. Benet L, Schwartz J, Oie S. Design and optimization of dosage regimens: pharmacokinetics data. In: Hardman J, Limbird L, Molinoff P, Ruddon R, Gilman A, eds. The pharmacological basis of therapeutics. New York: McGraw-Hill, 1996:1707.
104. Fromm G, Amores C, Thies W. Imipramine in epilepsy. Arch Neurol 1972;27:198-204.
105. Legg N, Swash M. Clinical note: seizures and EEG activation after trimipramine. Epilepsia 1974;15:131-135.
106. Blumer D. Antidepressant and double antidepressant treatment for the affective disorder of epilepsy. J Clin Psychiatry 1997;58:3-11.
107. Blumer D, Heilbronn M, Himmelhoch J. Indications for carbamazepine in mental illness: atypical psychiatric disorder or temporal lobe syndrome? Comp Psychiatry 1988;29:108-122.
108. Power B, Hackett L, Dusci L. Antidepressant toxicity and the need for identification and concentration monitoring in overdose. Clin Pharmacokinet 1995;29:154-171.
109. Swinkels J, Jonghe F. Safety of antidepressants. Int Clin Psychopharmacol 1995;9(suppl. 4):19-25.
110. Spiller H, Ramoska E, Krenzelok E. Bupropion overdose: a 3-year multicenter retrospective analysis. Am J Emerg Med 1994;12:43-45.
111. Rasmussen J, Johnson A. Incidence of seizures during treatment with antidepressants, including the new selective serotonin re-uptake inhibitor paroxetine. Proc 5th World Congr Biol Psychiatry 1991;40-41.
112. Peck A, Stern W, Watkinson C. Incidence of seizures during treatment with tricyclic antidepressant drugs and bupropion. J Clin Psychiatry 1983;44:197-201.
113. Curran S, De Pauw. Selecting an antidepressant for use in a patient with epilepsy. Safety considerations. Drug Safety 1998;18:125-133.
114. Ojemann L, Baugh-Bookman C, Dudley D. Effect of psychotropic medications on seizure control in patients with epilepsy. Neurology 1987;37:1525-1527.
115. Favale E, Rubino V, Mainardi P. Anticonvulsant effect of fluoxetine in humans. Neurology 1995;45:1926-1927
116. Schiwy W, Heath W, Delini-Stula. A therapeutic and side effect profile of a selective and reversible MAO-A inhibitor. Results of dose-findings trials in depressed patients. J Neural Transmiss 1989;28(suppl.):33-44.
117. Grimsley S, Jann M, Carter J. Increased carbamazepine plasma concentration after fluoxetine co-administration. Clin Pharmacol Ther 1991;50:10-15.
118. Pearson H. Interaction of fluoxetine with carbamazepine. J Clin Psychiatry 1990;51:126.
119. Fritze J, Unsorg B, Lanczik M. Interaction between carbamazepine and fluvoxamine. Acta Psychiatr Scand 1991;84:583-584
120. Delucchi G, Calabrese J. Anticonvulsants for the treatment of manic depression. Cleveland Clin J Med 1989;56:756-761.
121. Bell AJ, Cole A, Eccleston D, et al. Lithium neurotoxicity at normal therapeutic levels. Br J Psychiatry 1993;162:688-692.
122. Post R, Putnam F, Uhde T. Electroconvulsive therapy as an anticonvulsant: implications for its mechanisms of action in affective illness. In: Malitz S, Sackeim H, eds. Electroconvulsive therapy: clinical and basic research issues. New York: NY Academy of Sciences, 1986:
123. Stimmel GL, Dopheide JA. Psychotropic drug-induced reductions in seizure threshold: incidence and consequences. CNS Drugs 1996;5:37-50.